Eastman Kodak Company — Cyborg Score 5/10

Mixed
Diversified Imaging, Specialty Chemicals & Pharmaceuticals

Strategic Profile

Kodak's competitive advantage lies in its specialized imaging technologies, chemical expertise, and strong intellectual property portfolio. The company has strategically pivoted away from consumer digital photography toward higher-margin commercial print solutions and advanced specialty materials, positioning itself in niche markets with lower competitive intensity.

Cyborg Score Rationale

Kodak faces structural headwinds from declining print markets but benefits from specialized B2B niches and emerging opportunities in advanced materials. The company's profitability remains challenged by industry dynamics, though strategic repositioning efforts show promise.

Top Insights

  • Transitioned from consumer-facing photography to B2B commercial printing and specialty materials
  • Pharmaceutical segment provides relative stability and alternative revenue streams beyond imaging
  • Strong IP portfolio and proprietary chemical/imaging technologies create moat in niche markets
  • Print media headwinds offset by commercial print solutions demand and specialty materials growth

Named Competitors

  • Printing Solutions — Digital printing and imaging equipment
  • Print Technology — Imaging and optical products
  • Specialty Chemicals — Specialty chemicals and materials

Recent Developments

  • (2024) Continued focus on commercial print solutions and advanced materials expansion
  • (2023) Maintained diversified business model across printing, pharmaceuticals, and industrial segments
  • (2023) Advances in specialty coatings and high-performance materials for industrial applications

Open the full interactive Eastman Kodak Company report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →